Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese
Benefit-risk Evaluation of Bevacizumab in the treatment of Breast Cancer
WANG Sheng-ye, DU Xiang-hui
Chinese Journal of Clinical Pharmacology and Therapeutics . 2013, (1): 115 -120 .